Seeking AlphaBetting On The CAR-T RaceSeeking AlphaThis is a breakthrough moment for Chimeric Antigen Receptor T-cell (CAR-T) therapy that even has the competition cheering. Now, as we get back to investing, the competitive landscape and long run value… Continue reading
|
These hormones may make breast cancer act like stem cells
Futurity: Research News “Our laboratory is committed to identifying the cell mechanisms that bring about increased breast cancer risks. Recently, our research focused on special cells—which are called ‘cancer stem cell-like cells’—that induce aggressive tumor growth … |
Science Daily |
Study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumor immunity
Science Daily Immunotherapy, the use of the immune system to fight cancer, is revolutionizing treatment of this disease, and was selected by the journal Science as the major scientific advance of 2013. According to study leader David Sancho, “Cancer escapes the … |
Science Daily |
Study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumor immunity
Science Daily Immunotherapy, the use of the immune system to fight cancer, is revolutionizing treatment of this disease, and was selected by the journal Science as the major scientific advance of 2013. According to study leader David Sancho, “Cancer escapes the … |
Science Daily |
Study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumor immunity
Science Daily Immunotherapy, the use of the immune system to fight cancer, is revolutionizing treatment of this disease, and was selected by the journal Science as the major scientific advance of 2013. According to study leader David Sancho, “Cancer escapes the … |
|
MS News That Caught My Eye This Week: Stem Cell Cautions, Myelin Mystery, Amprya Study and Zinbryta in the EU
Multiple Sclerosis News Today I read a lot of comments on various social media sites from MS patients who have traveled outside the U.S. to be treated with stem cells. Some of these patients have reported excellent results and a reversal of symptoms. Others have died. There’s a new … |
|
Regulatory Recon: FDA Accepts Spark’s Gene Therapy Application; Amgen Gets CRL for Osteoporosis Candidate …
Regulatory Focus Regulatory Reconnaissance is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory news stories from around the globe. Each weekday morning, we aim to bring you the latest highlights of new approvals … |